Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 2
2017 5
2018 7
2019 8
2020 10
2021 10
2022 8
2023 9
2024 3
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Nestor MS, et al. J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. J Cosmet Dermatol. 2021. PMID: 34741573 Free PMC article. Review.
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline in men and diffuse hair thinning in women, with frontal hairline retention, and can impact an individual's qual …
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding fr …
Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.
Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ. Kaiser M, et al. Clin Cosmet Investig Dermatol. 2023 May 31;16:1387-1406. doi: 10.2147/CCID.S385861. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37284568 Free PMC article. Review.
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women. Traditionally, topical minoxidil and oral finasteride have been the standard of care yielding mixed results. New treatments such as Low-Level Laser Therapy (LLLT), micr …
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women. Traditionally, topical minox …
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V. Gupta AK, et al. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2112-2125. doi: 10.1111/jdv.15081. Epub 2018 Jul 11. J Eur Acad Dermatol Venereol. 2018. PMID: 29797431
Androgenetic alopecia, or male/female pattern baldness, is the most common type of progressive hair loss disorder. ...LLLT was low; and finasteride (male) vs. placebo, LLLT vs. sham, PRP vs. placebo and finasteride vs. minoxidil 2% was very low. Result …
Androgenetic alopecia, or male/female pattern baldness, is the most common type of progressive hair loss disorder. ...L …
Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials.
Jafarzadeh A, Pour Mohammad A, Keramati H, Zeinali R, Khosravi M, Goodarzi A. Jafarzadeh A, et al. Stem Cell Res Ther. 2024 Jun 18;15(1):176. doi: 10.1186/s13287-024-03800-6. Stem Cell Res Ther. 2024. PMID: 38886861 Free PMC article.
The most frequently studied skin diseases were androgenetic alopecia (AGA) (45.3%) and vitiligo (31.2%). The most common regenerative methods investigated for these diseases were PRP and the transplantation of autologous epidermal melanocyte/keratinocyte cells, resp …
The most frequently studied skin diseases were androgenetic alopecia (AGA) (45.3%) and vitiligo (31.2%). The most common regenerative …
Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality.
Gupta AK, Bamimore MA, Foley KA. Gupta AK, et al. J Dermatolog Treat. 2022 Feb;33(1):62-72. doi: 10.1080/09546634.2020.1749547. Epub 2020 Apr 13. J Dermatolog Treat. 2022. PMID: 32250713 Free article.
BACKGROUND AND OBJECTIVE: Various treatments exist for androgenetic alopecia (AGA); we determined the relative efficacies of non-surgical AGA monotherapies separately for men and women. ...Separate networks were used for men and women; for each network, a Bay …
BACKGROUND AND OBJECTIVE: Various treatments exist for androgenetic alopecia (AGA); we determined the relative efficacies of non-surg …
Combination Approaches for Combatting Hair Loss.
Rose PT. Rose PT. Dermatol Clin. 2021 Jul;39(3):479-485. doi: 10.1016/j.det.2021.04.004. Epub 2021 May 15. Dermatol Clin. 2021. PMID: 34053599 Review.
By age 60 years, it is estimated that 80% of women experience hair loss. Other nonandrogenetic forms of hair loss occur due to various dermatologic disorders as well as systemic disorders. Children may also experience significant hair …
By age 60 years, it is estimated that 80% of women experience hair loss. Other nonandrogenetic forms of hair …
Comparative Efficacy of Topical Minoxidil Alone Against Combination of Topical Minoxidil and Platelet Rich Plasma in Women with Female Pattern Hair Loss-A Pilot, Open Randomised Trial.
Agarwal A, Mendiratta V. Agarwal A, et al. Indian J Dermatol. 2023 Jan-Feb;68(1):121. doi: 10.4103/ijd.ijd_461_22. Indian J Dermatol. 2023. PMID: 37151237 Free PMC article.
BACKGROUND: Female pattern hair loss (FPHL) affects a significant proportion of population and poses a major therapeutic challenge. AIMS AND OBJECTIVES: To compare the efficacy and safety profile of combination of topical minoxidil 2% plus platelet rich plasma (P …
BACKGROUND: Female pattern hair loss (FPHL) affects a significant proportion of population and poses a major therapeutic chall …
Minimally invasive procedures for the management of female pattern hair loss.
Melo DF, Cortez de Almeida RF, Frattini SC, Santos LDN, Ramos PM. Melo DF, et al. J Cosmet Dermatol. 2022 Nov;21(11):5405-5408. doi: 10.1111/jocd.15160. Epub 2022 Jun 25. J Cosmet Dermatol. 2022. PMID: 35713007 Review.
BACKGROUND: Female Pattern Hair Loss (FPHL) is one of the most common types of hair loss in women. It is characterized by progressive follicular miniaturization leading to diffuse hair thinning over the midfrontal scalp with a negative im …
BACKGROUND: Female Pattern Hair Loss (FPHL) is one of the most common types of hair loss in women. It is …
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Tay WC, Cheng SW, Lee JS, Clavel C, Wang EC. Tay WC, et al. Ital J Dermatol Venerol. 2025 Oct;160(5):438-452. doi: 10.23736/S2784-8671.25.08232-5. Epub 2025 Jul 8. Ital J Dermatol Venerol. 2025. PMID: 40627439 Free article. Review.
Hair loss in both men and women significantly impact quality of life and often has modest treatment outcomes. ...In androgenetic alopecia, microneedling, lasers, LLLT, and PRP have shown efficacy in increasing hair density and thickness. …
Hair loss in both men and women significantly impact quality of life and often has modest treatment outcomes. ...In and …
Effectiveness of platelet-rich plasma in treating female hair loss: A systematic review and meta-analysis of randomized controlled trials.
Yuan J, He Y, Wan H, Gao Y. Yuan J, et al. Skin Res Technol. 2024 Aug;30(8):e70004. doi: 10.1111/srt.70004. Skin Res Technol. 2024. PMID: 39177365 Free PMC article.
BACKGROUND: Hair loss profoundly affects women's physical appearance and psychological health. Platelet-rich plasma (PRP) therapy has gained attention as a potential treatment for female hair loss. ...Adverse effects were generally …
BACKGROUND: Hair loss profoundly affects women's physical appearance and psychological health. Platelet-rich pla …
59 results